These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26989708)

  • 1. Comparison of Th1 and Th2 responses in non-healing and healing patients with cutaneous leishmaniasis.
    Shahi M; Mohajery M; Shamsian SA; Nahrevanian H; Yazdanpanah SM
    Rep Biochem Mol Biol; 2013 Apr; 1(2):43-8. PubMed ID: 26989708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
    Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response in cutaneous leishmaniasis patients with healing
    Miramin-Mohammadi A; Javadi A; Eskandari SE; Mortazavi H; Rostami MN; Khamesipour A
    Iran J Microbiol; 2020 Jun; 12(3):249-255. PubMed ID: 32685122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
    Skeiky YA; Guderian JA; Benson DR; Bacelar O; Carvalho EM; Kubin M; Badaro R; Trinchieri G; Reed SG
    J Exp Med; 1995 Apr; 181(4):1527-37. PubMed ID: 7699334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis.
    Ajdary S; Riazi-Rad F; Alimohammadian MH; Pakzad SR
    J Infect; 2009 Aug; 59(2):139-43. PubMed ID: 19560211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways.
    Bamorovat M; Sharifi I; Aflatoonian MR; Sadeghi B; Shafiian A; Oliaee RT; Keyhani A; Afshar AA; Khosravi A; Mostafavi M; Parizi MH; Khatami M; Arefinia N
    Int Immunopharmacol; 2019 Apr; 69():321-327. PubMed ID: 30771740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulator and effector functions of T-cell subsets in human Leishmania infections.
    Kemp M
    APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
    Wolday D; Berhe N; Britton S; Akuffo H
    AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Garlic induces a shift in cytokine pattern in Leishmania major-infected BALB/c mice.
    Ghazanfari T; Hassan ZM; Ebtekar M; Ahmadiani A; Naderi G; Azar A
    Scand J Immunol; 2000 Nov; 52(5):491-5. PubMed ID: 11119248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
    Scott P
    J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T helper (h)1/Th2 and Leishmania: paradox rather than paradigm.
    Alexander J; Bryson K
    Immunol Lett; 2005 Jun; 99(1):17-23. PubMed ID: 15894106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine gene expression in healing and non-healing cases of cutaneous leishmaniasis in response to in vitro stimulation with recombinant gp63 using semi-quantitative RT-PCR.
    Habibi GR; Khamesipour A; McMaster WR; Mahboudi F
    Scand J Immunol; 2001 Oct; 54(4):414-20. PubMed ID: 11555409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design.
    Moafi M; Rezvan H; Sherkat R; Taleban R; Asilian A; Zarkesh Esfahani SH; Nilforoushzadeh MA; Jaffary F; Feizi A
    BMJ Open; 2017 Jan; 7(1):e013006. PubMed ID: 28132002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profile and pathology in human leishmaniasis.
    Ribeiro-de-Jesus A; Almeida RP; Lessa H; Bacellar O; Carvalho EM
    Braz J Med Biol Res; 1998 Jan; 31(1):143-8. PubMed ID: 9686192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.
    Sypek JP; Chung CL; Mayor SE; Subramanyam JM; Goldman SJ; Sieburth DS; Wolf SF; Schaub RG
    J Exp Med; 1993 Jun; 177(6):1797-802. PubMed ID: 8098733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunopathology of American tegumentary leishmaniasis].
    Castés M; Tapia FJ
    Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis.
    Bomfim G; Nascimento C; Costa J; Carvalho EM; Barral-Netto M; Barral A
    Exp Parasitol; 1996 Nov; 84(2):188-94. PubMed ID: 8932768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
    Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endemically exposed asymptomatic individuals show no increase in the specific Leishmania (Viannia) panamensis-Th1 immune response in comparison to patients with localized cutaneous leishmaniasis.
    Trujillo CM; Robledo SM; Franco JL; Velez ID; Erb KJ; Patiño PJ
    Parasite Immunol; 2002; 24(9-10):455-62. PubMed ID: 12654087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.